BLT Share Price Performance
NZ$0.016
0.00 (6.67%)
Price NZ$0.016
Share Pricen/a
Analysis Article • Dec 03
BLIS Technologies Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 9 Fair Values set on narratives written by author
BLT Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
BLIS Technologies Limited Key Details
About BLT
- Founded
- 2000
- Employees
- 43
- CEO
- WebsiteView website
BLIS Technologies Limited develops and sells probiotics in New Zealand, the Asia Pacific, Europe, the Middle East, Africa, and North America. It offers BLIS K12, an oral probiotic that supports ear, nose, and throat health, as well as immunity and bad breath; BLIS M18, an oral probiotic for teeth and gums health; and BLIS Q24, a probiotic that balances the skin microbiome and restores skin’s health. The company’s products are used in various health areas, including ear, nose, throat, immune, dental, and skin, as well as pet oral. It exports its products. The company was formerly known as Tarn Holdings Limited and changed its name to BLIS Technologies Limited in August 2000. BLIS Technologies Limited was incorporated in 2000 and is headquartered in Dunedin, New Zealand.